TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bronstein, Gewirtz & Grossman Llc
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

A class action lawsuit has been filed against DexCom, Inc. alleging that the company made unauthorized material design changes to its G6 and G7 glucose monitoring devices without FDA approval, rendering them less reliable and presenting health risks to users. The lawsuit covers investors who purchased DexCom securities between January 8, 2024 and September 17, 2025. The lead plaintiff deadline is December 26, 2025.

Insights
BK   neutral

Mentioned as having a speaker (Jose Minaya) at the forum, with no specific positive or negative context


DXCM   negative

The company faces a class action lawsuit alleging material misstatements regarding unauthorized FDA design changes to its glucose monitoring devices, reduced device reliability, health risks to users, and overstated product enhancements. These allegations expose DexCom to regulatory enforcement action, legal liability, reputational damage, and financial harm.